2,3-Dihydroxyquinoxaline - CAS 15804-19-0
Catalog: |
BB011389 |
Product Name: |
2,3-Dihydroxyquinoxaline |
CAS: |
15804-19-0 |
Synonyms: |
2,3-Quinoxalinedione, 1,4-dihydro-; 1,4-Dihydro-2,3-quinoxalinedione; 1,2,3,4-Tetrahydro-2,3-dioxoquinoxaline; 2,3(1H,4H)-Quinoxalinedione; 2,3-Quinoxalinediol; 3-Hydroxy-1,2-dihydroquinoxalin-2-one; NSC 8698; NSC 9431 |
Related CAS: | 6287-20-3 (Deleted CAS)
|
IUPAC Name: | 1,4-dihydroquinoxaline-2,3-dione |
Description: | 2,3-Dihydroxyquinoxaline (CAS# 15804-19-0) is a useful research chemical. |
Molecular Weight: | 162.15 |
Molecular Formula: | C8H6N2O2 |
Canonical SMILES: | C1=CC=C2C(=C1)NC(=O)C(=O)N2 |
InChI: | InChI=1S/C8H6N2O2/c11-7-8(12)10-6-4-2-1-3-5(6)9-7/h1-4H,(H,9,11)(H,10,12) |
InChI Key: | ABJFBJGGLJVMAQ-UHFFFAOYSA-N |
Boiling Point: | 470.9±40.0°C at 760 mmHg |
Melting Point: | >300°C |
Purity: | ≥95% |
Density: | 1.336±0.06 g/cm3 |
Appearance: | Off-white Solid |
Storage: | Store at RT |
MDL: | MFCD00006723 |
LogP: | 0.21640 |
Vapor Pressure: | 0.00000005 [mmHg] |
GHS Hazard Statement: | H302 (95%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P310, P312, P321, P330, P332+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-113264978-A | Novel molecular targeting anti-tumor aza steroid derivative based on lipotoxicity, preparation and application thereof | 20210109 |
JP-2021157173-A | Photosensitive resin composition, cured film, laminate, electronic components and organic EL display device | 20200326 |
JP-2021155466-A | Resin composition, cured film, method for manufacturing cured film, organic EL display device | 20200325 |
WO-2021182499-A1 | Organic el display device and photosensitive resin composition | 20200313 |
JP-2021138905-A | glue | 20200302 |
PMID | Publication Date | Title | Journal |
31893549 | 20200215 | Design, synthesis and biological evaluation of quinoxaline compounds as anti-HIV agents targeting reverse transcriptase enzyme | European journal of medicinal chemistry |
22743583 | 20120811 | Slow magnetic relaxation in carbonato-bridged dinuclear lanthanide(III) complexes with 2,3-quinoxalinediolate ligands | Chemical communications (Cambridge, England) |
22220982 | 20120116 | Spin-canting magnetization in an unusual Co4 cluster-based layer compound from a 2,3-dihydroxyquinoxaline ligand | Inorganic chemistry |
21836991 | 20110701 | 1,4-Dihydro-quinoxaline-2,3-dione-5-nitro-isophthalic acid-water (1/1/1) | Acta crystallographica. Section E, Structure reports online |
21390364 | 20110421 | Slow magnetic relaxation in a cobalt magnetic chain | Chemical communications (Cambridge, England) |
Complexity: | 203 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 162.042927438 |
Formal Charge: | 0 |
Heavy Atom Count: | 12 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 162.042927438 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 58.2 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Quinoxalines
Customers Also Viewed
-
[138169-43-4]
MTS Reagent
-
[55408-10-1]
Ethyl Tetrazole-5-carboxylate
-
[1427004-19-0]
DBCO-PEG4-NHS ester
-
[1263166-91-1]
endo-BCN-PNP-carbonate
-
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
-
[1643-20-5]
N,N-dimethyldodecan-1-amine oxide
INDUSTRY LEADERS TRUST OUR PRODUCTS